V025-5129 Screening compound: N-[(4-fluorophenyl)methyl]-2-[(4-methyl-2-oxo-1-propyl-1,2-dihydroquinolin-7-yl)oxy]acetamide

V025-5129 Screening compound: N-[(4-fluorophenyl)methyl]-2-[(4-methyl-2-oxo-1-propyl-1,2-dihydroquinolin-7-yl)oxy]acetamide
V025-5129 Screening compound: N-[(4-fluorophenyl)methyl]-2-[(4-methyl-2-oxo-1-propyl-1,2-dihydroquinolin-7-yl)oxy]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V025-5129
N-[(4-fluorophenyl)methyl]-2-[(4-methyl-2-oxo-1-propyl-1,2-dihydroquinolin-7-yl)oxy]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V025-5129

Molecular Formula

C22H23FN2O3 (C22 H23 FN2 O3)

Compound Name

N-[(4-fluorophenyl)methyl]-2-[(4-methyl-2-oxo-1-propyl-1,2-dihydroquinolin-7-yl)oxy]acetamide

IUPAC name

N-[(4-fluorophenyl)methyl]-2-[(4-methyl-2-oxo-1-propyl-12-dihydroquinolin-7-yl)oxy]acetamide

SMILES

CCCN(c(cc(cc1)OCC(NCc(cc2)ccc2F)=O)c1C(C)=C1)C1=O

InChI

InChI=1S/C22H23FN2O3/c1-3-10-25-20-12-18(8-9-19(20)15(2)11-22(25)27)28-14-21(26)24-13-16-4-6-17(23)7-5-16/h4-9,11-12H,3,10,13-14H2,1-2H3,(H,24,26)

InChI Key

UMWHSIDGNHSHGZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14284753

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.43

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.720

Distribution Coefficient, logD

3.720

Water Solubility, LogSw

-4.00

Polar Surface Area

47.568

Acid Dissociation Constant (pKa)

12.73

Base Dissociation Constant (pKb)

-2.24

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

27.30

V025-5129 in Drug Discovery

Included in Screening Libraries

Receptor-type Protein Tyrosine Phosphatases Library (3746 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Nervous system
  • Female
  • Metabolic
  • Endocrine
Targets:
  • Phosphatases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V025-5129 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V025-5129?
Check Price and Availability of V025-5129, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V025-5129 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V025-5129
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V025-5129
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V025-5129 available by request